Systematic Reviews
Copyright ©The Author(s) 2025.
World J Gastrointest Endosc. Jul 16, 2025; 17(7): 108541
Published online Jul 16, 2025. doi: 10.4253/wjge.v17.i7.108541
Table 1 Characteristics of included diagnostic test accuracy studies
Ref.
Study design
Location of lesion
Sample size
Inclusion criteria
Diagnostic intervention
Gold standard
Findings
Center type
Novis et al, 2010[9]Comparative studyDistal46Biliary obstructionEUS-FNA and ERCPHistology, surgery, and follow-upBenign lesions (n = 7) and malignant lesions (n = 37)SC
Fritscher-Ravens et al, 2004[10]ProspectiveProximal44Patients with obstructive jaundice and a clinical suspicion of cancerEUS-FNAAutopsy, surgery, or follow-upBenign (n = 12) and malignant (n = 31)SC
Ohshima et al, 2011[11]ProspectiveBiliary22Patients with suspected malignant biliary stricturesEUS-FNAHistology, surgery, and follow-upMalignant (n = 16) and benign (n = 6)SC
Weilert et al, 2014[12]ProspectiveBiliary51Patients with suspected pancreaticobiliary pathologiesEUS-FNA and ERCPSurgery, definitive findings, and follow-upBenign (n = 3) and malignant (n = 48)SC
DeWitt et al, 2006[13]ProspectiveProximal24Patients with suspected or confirmed proximal biliary stricturesEUS-FNASurgical pathology findings and follow-upMalignant (n = 17) and benign (n = 7)SC
Eloubeidi et al, 2004[17]ProspectiveBiliary25Patients with common bile duct stricturesEUS-FNAFollow-up and surgical pathologyMalignant (n = 31) and benign (n = 7)SC
Rösch et al, 2004[14]ProspectiveBiliary50Patients with indeterminate biliary stricturesEUS-FNA and ERCPFollow-up and surgical pathology or other biopsy resultsMalignant (n = 28) and benign (n = 22)SC
Lee et al, 2019[15]ProspectiveDistal181Patients with suspected malignant biliary stricturesEUS-FNA, ERCP, and POC-FBSurgical pathology findings and malignant diagnosis after biopsy or during follow-upMalignant (n = 51) and benign (n = 8)MC
Yeo et al, 2019[16]RetrospectiveBiliary93Patients with suspected biliary stricturesEUS-TS and ERCP-TSHistopathology findings based on the surgical specimen, cytology findings of either EUS-TS or ERCP-TS, or during clinical follow-upMalignant (n = 70) and benign (n = 16)MC
Lee et al, 2017[18]ProspectiveBiliary178Patients with suspected malignant biliary stricturesERCP with TPB and EUS-FNAHistopathologic findings of the surgical specimens, diagnosis based on TPB or EUS-FNAB, or during the clinical imaging on follow-upMalignant (n = 171) and benign (n = 7)MC